NCIt definition : A preparation of autologous T-lymphocytes that have been genetically modified to express
a T-cell receptor (TCR) specific for the human leukocyte antigen (HLA)-A*02:01-restricted
human papillomavirus type 16 isoform E7 protein (HPV16 E7) with potential antineoplastic
activity. Upon isolation, transduction, expansion ex vivo and re-introduction into
the patient, the autologous HPV16 E7-specific HLA-A*02:01-restricted T-lymphocytes
KITE-439 target and bind HPV16 E7-expressing tumor cells. This may lead to cytotoxic
T-lymphocyte (CTL)-mediated elimination of tumor cells expressing the HPV16 E7 antigen.
HPV16 E7, a cell surface glycoprotein and tumor-associated antigen (TAA), is overexpressed
in various HPV-mediated cancers.;